These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500 [TBL] [Abstract][Full Text] [Related]
5. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study. Dobrinas M; Crettol S; Oneda B; Lahyani R; Rotger M; Choong E; Lubomirov R; Csajka C; Eap CB Pharmacogenet Genomics; 2013 Feb; 23(2):84-93. PubMed ID: 23249875 [TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240 [TBL] [Abstract][Full Text] [Related]
7. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905 [TBL] [Abstract][Full Text] [Related]
8. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006 [TBL] [Abstract][Full Text] [Related]
9. PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites. Tsai HJ; Wang SC; Tian JN; Chang TK; Ho IK; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Liu YL J Clin Psychopharmacol; 2013 Feb; 33(1):137-40. PubMed ID: 23288240 [No Abstract] [Full Text] [Related]
10. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732 [TBL] [Abstract][Full Text] [Related]
11. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility. Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of the human µ-opioid receptor. Kasai S; Ikeda K Pharmacogenomics; 2011 Sep; 12(9):1305-20. PubMed ID: 21919606 [TBL] [Abstract][Full Text] [Related]
13. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians. Daher M; Costa FM; Neves FA Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975 [TBL] [Abstract][Full Text] [Related]
14. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study. AlMeman AA; Ismail R; Perola M Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles. Restrepo JG; Martínez C; García-Agúndez A; Gaviria E; Laguna JJ; García-Martín E; Agúndez JA Pharmacogenet Genomics; 2011 Dec; 21(12):773-8. PubMed ID: 21886015 [TBL] [Abstract][Full Text] [Related]
16. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences. Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759 [TBL] [Abstract][Full Text] [Related]
17. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. Wang SC; Ho IK; Tsou HH; Tian JN; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Chen CY; Liu SC; Wu HY; Chan HW; Tsai MH; Lin PS; Liu YL J Clin Psychopharmacol; 2011 Aug; 31(4):463-9. PubMed ID: 21694616 [TBL] [Abstract][Full Text] [Related]
18. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia. Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856 [TBL] [Abstract][Full Text] [Related]
19. The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia. Pettersson FD; Grönbladh A; Nyberg F; Sundström-Poromaa I; Åkerud H Reprod Sci; 2012 Sep; 19(9):962-7. PubMed ID: 22527985 [TBL] [Abstract][Full Text] [Related]
20. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]